Salvia Divinorum: The Less-Known Psychedelic and Its Properties


(MENAFN- Investor Brand Network) The popularity of psychedelics has been growing as the research conducted on these substances for their therapeutic benefits increases. Substances such as DMT, LSD, MDMA and psilocybin are the most studied as well as the most common psychedelics while others, including salvia divinorum, aren't popularly known.

Salvia divinorum is a psychoactive plant used in rituals in Mazatec shamanic ceremonies. The plant species is found in the mountainous Sierra Mazateca area near Mexico's Oaxaca City…

Read more >>

NOTE TO INVESTORS: The latest news and updates relating to Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) available in the company's newsroom at 

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text“Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit 

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: 

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California

415.949.5050 Office

PsychedelicNewsWire is part of the InvestorBrandNetwork .

MENAFN21082021000224011066ID1102655199


Investor Brand Network

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.